nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—HTR2B—Raloxifene—osteoporosis	0.23	0.315	CbGbCtD
Ergotamine—CYP1A2—Estropipate—osteoporosis	0.0815	0.112	CbGbCtD
Ergotamine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0459	0.0631	CbGbCtD
Ergotamine—CYP3A4—Estropipate—osteoporosis	0.0427	0.0586	CbGbCtD
Ergotamine—CYP3A4—Calcitriol—osteoporosis	0.0427	0.0586	CbGbCtD
Ergotamine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0386	0.0529	CbGbCtD
Ergotamine—CYP3A4—Ergocalciferol—osteoporosis	0.0342	0.0469	CbGbCtD
Ergotamine—CYP1A2—Estradiol—osteoporosis	0.0339	0.0465	CbGbCtD
Ergotamine—ABCB1—Conjugated Estrogens—osteoporosis	0.0337	0.0463	CbGbCtD
Ergotamine—ABCB1—Estradiol—osteoporosis	0.0296	0.0406	CbGbCtD
Ergotamine—CYP3A4—Raloxifene—osteoporosis	0.0285	0.0391	CbGbCtD
Ergotamine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0275	0.0378	CbGbCtD
Ergotamine—CYP3A4—Cholecalciferol—osteoporosis	0.022	0.0302	CbGbCtD
Ergotamine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0202	0.0277	CbGbCtD
Ergotamine—CYP3A4—Estradiol—osteoporosis	0.0177	0.0243	CbGbCtD
Ergotamine—Cyanosis—Conjugated Estrogens—osteoporosis	0.00387	0.0257	CcSEcCtD
Ergotamine—Bradycardia—Calcium Acetate—osteoporosis	0.00374	0.0248	CcSEcCtD
Ergotamine—Numbness—Zoledronate—osteoporosis	0.00344	0.0228	CcSEcCtD
Ergotamine—Sensory loss—Zoledronate—osteoporosis	0.00329	0.0218	CcSEcCtD
Ergotamine—Numbness—Estradiol—osteoporosis	0.00265	0.0175	CcSEcCtD
Ergotamine—Sensory loss—Estradiol—osteoporosis	0.00253	0.0168	CcSEcCtD
Ergotamine—Hypertension—Ergocalciferol—osteoporosis	0.00244	0.0161	CcSEcCtD
Ergotamine—Paraesthesia—Calcium Acetate—osteoporosis	0.00234	0.0155	CcSEcCtD
Ergotamine—Pain—Calcium Acetate—osteoporosis	0.00223	0.0148	CcSEcCtD
Ergotamine—Hypoaesthesia—Raloxifene—osteoporosis	0.00201	0.0133	CcSEcCtD
Ergotamine—Pain—Ergocalciferol—osteoporosis	0.00197	0.0131	CcSEcCtD
Ergotamine—Asthenia—Calcium Acetate—osteoporosis	0.00187	0.0124	CcSEcCtD
Ergotamine—Pruritus—Calcium Acetate—osteoporosis	0.00184	0.0122	CcSEcCtD
Ergotamine—Hypoaesthesia—Ethinyl Estradiol—osteoporosis	0.00168	0.0111	CcSEcCtD
Ergotamine—Vomiting—Calcium Acetate—osteoporosis	0.00166	0.011	CcSEcCtD
Ergotamine—Asthenia—Ergocalciferol—osteoporosis	0.00165	0.011	CcSEcCtD
Ergotamine—Vertigo—Estropipate—osteoporosis	0.00163	0.0108	CcSEcCtD
Ergotamine—Vertigo—Alendronate—osteoporosis	0.00161	0.0106	CcSEcCtD
Ergotamine—Vertigo—Raloxifene—osteoporosis	0.00158	0.0105	CcSEcCtD
Ergotamine—Vertigo—Ibandronate—osteoporosis	0.00156	0.0104	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.00156	0.0103	CcSEcCtD
Ergotamine—Nausea—Calcium Acetate—osteoporosis	0.00155	0.0103	CcSEcCtD
Ergotamine—Myalgia—Estropipate—osteoporosis	0.00154	0.0102	CcSEcCtD
Ergotamine—Paraesthesia—Etidronic acid—osteoporosis	0.00154	0.0102	CcSEcCtD
Ergotamine—Myalgia—Alendronate—osteoporosis	0.00152	0.0101	CcSEcCtD
Ergotamine—Hypertension—Ibandronate—osteoporosis	0.0015	0.00995	CcSEcCtD
Ergotamine—Myalgia—Raloxifene—osteoporosis	0.0015	0.00992	CcSEcCtD
Ergotamine—Myalgia—Ibandronate—osteoporosis	0.00148	0.00982	CcSEcCtD
Ergotamine—Hypertension—Calcitriol—osteoporosis	0.00147	0.00974	CcSEcCtD
Ergotamine—Bradycardia—Zoledronate—osteoporosis	0.00146	0.00965	CcSEcCtD
Ergotamine—Myalgia—Calcitriol—osteoporosis	0.00145	0.00961	CcSEcCtD
Ergotamine—Hypoaesthesia—Zoledronate—osteoporosis	0.00142	0.00943	CcSEcCtD
Ergotamine—Hypoaesthesia—Conjugated Estrogens—osteoporosis	0.00137	0.00908	CcSEcCtD
Ergotamine—Nausea—Ergocalciferol—osteoporosis	0.00137	0.00907	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Estropipate—osteoporosis	0.00135	0.00894	CcSEcCtD
Ergotamine—Paraesthesia—Estropipate—osteoporosis	0.00133	0.00881	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00133	0.00881	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.00131	0.00866	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00129	0.00857	CcSEcCtD
Ergotamine—Vertigo—Risedronate—osteoporosis	0.00129	0.00854	CcSEcCtD
Ergotamine—Paraesthesia—Ibandronate—osteoporosis	0.00127	0.00845	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00127	0.00839	CcSEcCtD
Ergotamine—Pain—Estropipate—osteoporosis	0.00127	0.00839	CcSEcCtD
Ergotamine—Pain—Alendronate—osteoporosis	0.00125	0.00827	CcSEcCtD
Ergotamine—Hypertension—Risedronate—osteoporosis	0.00124	0.0082	CcSEcCtD
Ergotamine—Pain—Raloxifene—osteoporosis	0.00123	0.00813	CcSEcCtD
Ergotamine—Myalgia—Risedronate—osteoporosis	0.00122	0.00809	CcSEcCtD
Ergotamine—Pain—Ibandronate—osteoporosis	0.00121	0.00805	CcSEcCtD
Ergotamine—Pruritus—Etidronic acid—osteoporosis	0.00121	0.00803	CcSEcCtD
Ergotamine—Pain—Calcitriol—osteoporosis	0.00119	0.00788	CcSEcCtD
Ergotamine—Hypertension—Pamidronate—osteoporosis	0.00118	0.0078	CcSEcCtD
Ergotamine—Myalgia—Pamidronate—osteoporosis	0.00116	0.00769	CcSEcCtD
Ergotamine—Vertigo—Zoledronate—osteoporosis	0.00112	0.00741	CcSEcCtD
Ergotamine—Hypoaesthesia—Estradiol—osteoporosis	0.0011	0.00727	CcSEcCtD
Ergotamine—Vomiting—Etidronic acid—osteoporosis	0.00109	0.00721	CcSEcCtD
Ergotamine—Tachycardia—Pamidronate—osteoporosis	0.00109	0.0072	CcSEcCtD
Ergotamine—Vertigo—Conjugated Estrogens—osteoporosis	0.00108	0.00714	CcSEcCtD
Ergotamine—Hypertension—Zoledronate—osteoporosis	0.00107	0.00712	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00107	0.00707	CcSEcCtD
Ergotamine—Asthenia—Estropipate—osteoporosis	0.00106	0.00704	CcSEcCtD
Ergotamine—Myalgia—Zoledronate—osteoporosis	0.00106	0.00702	CcSEcCtD
Ergotamine—Paraesthesia—Risedronate—osteoporosis	0.00105	0.00696	CcSEcCtD
Ergotamine—Pruritus—Estropipate—osteoporosis	0.00105	0.00694	CcSEcCtD
Ergotamine—Asthenia—Alendronate—osteoporosis	0.00105	0.00693	CcSEcCtD
Ergotamine—Pruritus—Alendronate—osteoporosis	0.00103	0.00684	CcSEcCtD
Ergotamine—Myalgia—Conjugated Estrogens—osteoporosis	0.00102	0.00676	CcSEcCtD
Ergotamine—Asthenia—Ibandronate—osteoporosis	0.00102	0.00675	CcSEcCtD
Ergotamine—Nausea—Etidronic acid—osteoporosis	0.00102	0.00674	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00101	0.00672	CcSEcCtD
Ergotamine—Pruritus—Ibandronate—osteoporosis	0.001	0.00666	CcSEcCtD
Ergotamine—Pain—Risedronate—osteoporosis	0.001	0.00663	CcSEcCtD
Ergotamine—Paraesthesia—Pamidronate—osteoporosis	0.000999	0.00662	CcSEcCtD
Ergotamine—Asthenia—Calcitriol—osteoporosis	0.000997	0.00661	CcSEcCtD
Ergotamine—Tachycardia—Zoledronate—osteoporosis	0.000992	0.00657	CcSEcCtD
Ergotamine—Pruritus—Calcitriol—osteoporosis	0.000983	0.00652	CcSEcCtD
Ergotamine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000955	0.00633	CcSEcCtD
Ergotamine—Pain—Pamidronate—osteoporosis	0.000951	0.0063	CcSEcCtD
Ergotamine—Vomiting—Estropipate—osteoporosis	0.000941	0.00624	CcSEcCtD
Ergotamine—Vomiting—Alendronate—osteoporosis	0.000927	0.00615	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000926	0.00614	CcSEcCtD
Ergotamine—Paraesthesia—Zoledronate—osteoporosis	0.000912	0.00605	CcSEcCtD
Ergotamine—Vomiting—Raloxifene—osteoporosis	0.000912	0.00604	CcSEcCtD
Ergotamine—Vomiting—Ibandronate—osteoporosis	0.000903	0.00598	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000891	0.00591	CcSEcCtD
Ergotamine—Vomiting—Calcitriol—osteoporosis	0.000884	0.00586	CcSEcCtD
Ergotamine—Nausea—Estropipate—osteoporosis	0.000879	0.00583	CcSEcCtD
Ergotamine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000878	0.00582	CcSEcCtD
Ergotamine—Pain—Zoledronate—osteoporosis	0.000869	0.00576	CcSEcCtD
Ergotamine—Nausea—Alendronate—osteoporosis	0.000866	0.00574	CcSEcCtD
Ergotamine—Vertigo—Estradiol—osteoporosis	0.000862	0.00571	CcSEcCtD
Ergotamine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000861	0.00571	CcSEcCtD
Ergotamine—Nausea—Raloxifene—osteoporosis	0.000852	0.00565	CcSEcCtD
Ergotamine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000849	0.00563	CcSEcCtD
Ergotamine—Nausea—Ibandronate—osteoporosis	0.000843	0.00559	CcSEcCtD
Ergotamine—Asthenia—Risedronate—osteoporosis	0.000839	0.00556	CcSEcCtD
Ergotamine—Pain—Conjugated Estrogens—osteoporosis	0.000837	0.00554	CcSEcCtD
Ergotamine—Hypertension—Estradiol—osteoporosis	0.000828	0.00549	CcSEcCtD
Ergotamine—Pruritus—Risedronate—osteoporosis	0.000828	0.00549	CcSEcCtD
Ergotamine—Nausea—Calcitriol—osteoporosis	0.000826	0.00547	CcSEcCtD
Ergotamine—Myalgia—Estradiol—osteoporosis	0.000817	0.00541	CcSEcCtD
Ergotamine—Asthenia—Pamidronate—osteoporosis	0.000798	0.00529	CcSEcCtD
Ergotamine—Pruritus—Pamidronate—osteoporosis	0.000787	0.00522	CcSEcCtD
Ergotamine—Tachycardia—Estradiol—osteoporosis	0.000764	0.00506	CcSEcCtD
Ergotamine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000763	0.00506	CcSEcCtD
Ergotamine—Vomiting—Risedronate—osteoporosis	0.000744	0.00493	CcSEcCtD
Ergotamine—Asthenia—Zoledronate—osteoporosis	0.000729	0.00483	CcSEcCtD
Ergotamine—Pruritus—Zoledronate—osteoporosis	0.000719	0.00476	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000713	0.00473	CcSEcCtD
Ergotamine—Nausea—Ethinyl Estradiol—osteoporosis	0.000713	0.00472	CcSEcCtD
Ergotamine—Vomiting—Pamidronate—osteoporosis	0.000707	0.00469	CcSEcCtD
Ergotamine—Paraesthesia—Estradiol—osteoporosis	0.000703	0.00466	CcSEcCtD
Ergotamine—Asthenia—Conjugated Estrogens—osteoporosis	0.000702	0.00465	CcSEcCtD
Ergotamine—Nausea—Risedronate—osteoporosis	0.000695	0.00461	CcSEcCtD
Ergotamine—Pruritus—Conjugated Estrogens—osteoporosis	0.000692	0.00459	CcSEcCtD
Ergotamine—Pain—Estradiol—osteoporosis	0.00067	0.00444	CcSEcCtD
Ergotamine—Nausea—Pamidronate—osteoporosis	0.000661	0.00438	CcSEcCtD
Ergotamine—Vomiting—Zoledronate—osteoporosis	0.000646	0.00428	CcSEcCtD
Ergotamine—Vomiting—Conjugated Estrogens—osteoporosis	0.000622	0.00412	CcSEcCtD
Ergotamine—Nausea—Zoledronate—osteoporosis	0.000603	0.004	CcSEcCtD
Ergotamine—Nausea—Conjugated Estrogens—osteoporosis	0.000581	0.00385	CcSEcCtD
Ergotamine—Asthenia—Estradiol—osteoporosis	0.000562	0.00372	CcSEcCtD
Ergotamine—Pruritus—Estradiol—osteoporosis	0.000554	0.00367	CcSEcCtD
Ergotamine—Vomiting—Estradiol—osteoporosis	0.000498	0.0033	CcSEcCtD
Ergotamine—Nausea—Estradiol—osteoporosis	0.000465	0.00308	CcSEcCtD
Ergotamine—ABCB1—Metabolism—P4HB—osteoporosis	2.64e-05	0.000219	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—IDH2—osteoporosis	2.64e-05	0.000219	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—KL—osteoporosis	2.62e-05	0.000217	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	2.62e-05	0.000217	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	2.62e-05	0.000217	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—SPP1—osteoporosis	2.61e-05	0.000216	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—KL—osteoporosis	2.61e-05	0.000216	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GAPDH—osteoporosis	2.59e-05	0.000215	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	2.58e-05	0.000214	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	2.58e-05	0.000214	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	2.58e-05	0.000214	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—POMC—osteoporosis	2.56e-05	0.000212	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—POMC—osteoporosis	2.54e-05	0.000211	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CALCA—osteoporosis	2.53e-05	0.00021	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—ADCY5—osteoporosis	2.53e-05	0.00021	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—RAP1A—osteoporosis	2.53e-05	0.00021	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—FGB—osteoporosis	2.52e-05	0.000209	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—KL—osteoporosis	2.5e-05	0.000207	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL6R—osteoporosis	2.49e-05	0.000207	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CALCA—osteoporosis	2.49e-05	0.000207	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CYP27A1—osteoporosis	2.48e-05	0.000206	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL6R—osteoporosis	2.48e-05	0.000206	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—POMC—osteoporosis	2.47e-05	0.000205	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CA2—osteoporosis	2.46e-05	0.000204	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—OXCT1—osteoporosis	2.46e-05	0.000204	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—SPP1—osteoporosis	2.45e-05	0.000203	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CALCA—osteoporosis	2.44e-05	0.000203	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—POMC—osteoporosis	2.43e-05	0.000202	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	2.43e-05	0.000202	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	2.43e-05	0.000202	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—POMC—osteoporosis	2.43e-05	0.000202	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ACP5—osteoporosis	2.41e-05	0.0002	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IRS2—osteoporosis	2.41e-05	0.0002	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—MGLL—osteoporosis	2.4e-05	0.000199	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.38e-05	0.000198	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	2.38e-05	0.000198	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	2.37e-05	0.000197	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—CYP19A1—osteoporosis	2.36e-05	0.000196	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IRS2—osteoporosis	2.36e-05	0.000196	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—LEP—osteoporosis	2.36e-05	0.000196	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—ADCY5—osteoporosis	2.36e-05	0.000195	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—IL6—osteoporosis	2.33e-05	0.000193	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—LEP—osteoporosis	2.31e-05	0.000191	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—KL—osteoporosis	2.3e-05	0.000191	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SPP1—osteoporosis	2.28e-05	0.000189	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	2.27e-05	0.000188	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—KL—osteoporosis	2.26e-05	0.000188	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—ESR1—osteoporosis	2.25e-05	0.000187	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—TPI1—osteoporosis	2.24e-05	0.000186	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—POMC—osteoporosis	2.24e-05	0.000186	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—KL—osteoporosis	2.22e-05	0.000184	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IRS2—osteoporosis	2.21e-05	0.000184	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	2.21e-05	0.000184	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—POMC—osteoporosis	2.21e-05	0.000183	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—ESR1—osteoporosis	2.2e-05	0.000183	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—IL6—osteoporosis	2.2e-05	0.000182	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL6R—osteoporosis	2.19e-05	0.000182	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—LEP—osteoporosis	2.17e-05	0.00018	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—POMC—osteoporosis	2.16e-05	0.000179	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL6R—osteoporosis	2.15e-05	0.000179	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	2.13e-05	0.000176	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—P4HB—osteoporosis	2.11e-05	0.000175	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	2.11e-05	0.000175	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IRS1—osteoporosis	2.1e-05	0.000174	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GAPDH—osteoporosis	2.07e-05	0.000172	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—ESR1—osteoporosis	2.07e-05	0.000172	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IRS2—osteoporosis	2.06e-05	0.000171	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—KL—osteoporosis	2.06e-05	0.000171	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IRS1—osteoporosis	2.06e-05	0.000171	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SPP1—osteoporosis	2.06e-05	0.000171	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—ADCY5—osteoporosis	2.05e-05	0.00017	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ENO1—osteoporosis	2.04e-05	0.00017	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	2.04e-05	0.000169	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—IDH2—osteoporosis	2.04e-05	0.000169	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—POMC—osteoporosis	2.02e-05	0.000168	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TGFB1—osteoporosis	2.02e-05	0.000168	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—RAP1A—osteoporosis	2.02e-05	0.000167	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—LEP—osteoporosis	2.02e-05	0.000167	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PSMA5—osteoporosis	2.01e-05	0.000167	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PSMA2—osteoporosis	2.01e-05	0.000167	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	2.01e-05	0.000167	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SPP1—osteoporosis	1.99e-05	0.000165	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—POMC—osteoporosis	1.98e-05	0.000164	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SPP1—osteoporosis	1.98e-05	0.000164	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL6R—osteoporosis	1.97e-05	0.000164	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	1.96e-05	0.000163	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	1.96e-05	0.000162	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IGF1—osteoporosis	1.95e-05	0.000162	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL6R—osteoporosis	1.93e-05	0.00016	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IRS1—osteoporosis	1.93e-05	0.00016	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ADCY5—osteoporosis	1.93e-05	0.00016	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—ESR1—osteoporosis	1.93e-05	0.00016	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—GPX1—osteoporosis	1.92e-05	0.00016	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.92e-05	0.000159	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IGF1—osteoporosis	1.91e-05	0.000158	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	1.89e-05	0.000157	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ACP5—osteoporosis	1.86e-05	0.000155	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—POMC—osteoporosis	1.86e-05	0.000155	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	1.86e-05	0.000154	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—MYC—osteoporosis	1.83e-05	0.000152	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TGFB1—osteoporosis	1.83e-05	0.000151	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—LEP—osteoporosis	1.82e-05	0.000151	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL6R—osteoporosis	1.82e-05	0.000151	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ADCY5—osteoporosis	1.8e-05	0.00015	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IRS1—osteoporosis	1.8e-05	0.000149	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IRS2—osteoporosis	1.8e-05	0.000149	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IGF1—osteoporosis	1.79e-05	0.000149	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IRS2—osteoporosis	1.79e-05	0.000148	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—MTHFR—osteoporosis	1.77e-05	0.000147	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	1.77e-05	0.000147	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.76e-05	0.000146	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—LEP—osteoporosis	1.76e-05	0.000146	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—LEP—osteoporosis	1.75e-05	0.000145	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SPP1—osteoporosis	1.74e-05	0.000145	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	1.74e-05	0.000144	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	1.74e-05	0.000144	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—POMC—osteoporosis	1.73e-05	0.000144	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—TPI1—osteoporosis	1.73e-05	0.000144	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—MYC—osteoporosis	1.73e-05	0.000143	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TGFB1—osteoporosis	1.72e-05	0.000143	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SPP1—osteoporosis	1.72e-05	0.000142	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.71e-05	0.000142	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6R—osteoporosis	1.69e-05	0.00014	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.68e-05	0.000139	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—ESR1—osteoporosis	1.68e-05	0.000139	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.67e-05	0.000139	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—ESR1—osteoporosis	1.67e-05	0.000139	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IGF1—osteoporosis	1.67e-05	0.000138	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CYP19A1—osteoporosis	1.63e-05	0.000136	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ENO1—osteoporosis	1.63e-05	0.000135	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—P4HB—osteoporosis	1.63e-05	0.000135	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.62e-05	0.000135	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.61e-05	0.000134	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PSMA2—osteoporosis	1.61e-05	0.000133	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PSMA5—osteoporosis	1.61e-05	0.000133	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.6e-05	0.000133	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.6e-05	0.000133	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IRS2—osteoporosis	1.58e-05	0.000131	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IRS1—osteoporosis	1.57e-05	0.00013	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.56e-05	0.00013	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.56e-05	0.00013	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.56e-05	0.000129	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.56e-05	0.000129	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.55e-05	0.000129	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—LEP—osteoporosis	1.54e-05	0.000128	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.53e-05	0.000127	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.52e-05	0.000126	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—LEP—osteoporosis	1.52e-05	0.000126	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—POMC—osteoporosis	1.51e-05	0.000125	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	1.5e-05	0.000125	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—POMC—osteoporosis	1.5e-05	0.000125	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1.49e-05	0.000124	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—IL6—osteoporosis	1.49e-05	0.000124	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.49e-05	0.000123	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ESR1—osteoporosis	1.47e-05	0.000122	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6R—osteoporosis	1.47e-05	0.000122	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.47e-05	0.000122	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—IL6—osteoporosis	1.46e-05	0.000121	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IGF1—osteoporosis	1.45e-05	0.000121	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.45e-05	0.00012	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.44e-05	0.00012	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—POMC—osteoporosis	1.44e-05	0.000119	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.42e-05	0.000118	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—POMC—osteoporosis	1.42e-05	0.000118	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.41e-05	0.000117	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	1.4e-05	0.000116	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	1.38e-05	0.000115	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.38e-05	0.000115	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IRS1—osteoporosis	1.38e-05	0.000114	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IL6—osteoporosis	1.38e-05	0.000114	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—IL6—osteoporosis	1.37e-05	0.000114	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.35e-05	0.000112	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ADCY5—osteoporosis	1.33e-05	0.000111	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—GPX1—osteoporosis	1.33e-05	0.00011	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.33e-05	0.00011	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—POMC—osteoporosis	1.33e-05	0.00011	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.32e-05	0.000109	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—POMC—osteoporosis	1.3e-05	0.000108	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.3e-05	0.000108	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL6—osteoporosis	1.3e-05	0.000108	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6R—osteoporosis	1.29e-05	0.000107	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—POMC—osteoporosis	1.28e-05	0.000106	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IGF1—osteoporosis	1.28e-05	0.000106	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL6—osteoporosis	1.27e-05	0.000106	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.27e-05	0.000106	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ENO1—osteoporosis	1.26e-05	0.000104	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.25e-05	0.000104	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	1.25e-05	0.000103	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PSMA2—osteoporosis	1.24e-05	0.000103	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PSMA5—osteoporosis	1.24e-05	0.000103	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.23e-05	0.000102	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	1.23e-05	0.000102	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—MTHFR—osteoporosis	1.23e-05	0.000102	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.19e-05	9.85e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MYC—osteoporosis	1.17e-05	9.71e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFB1—osteoporosis	1.17e-05	9.69e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.16e-05	9.61e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	1.15e-05	9.55e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MYC—osteoporosis	1.15e-05	9.51e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFB1—osteoporosis	1.14e-05	9.49e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.14e-05	9.47e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL6—osteoporosis	1.11e-05	9.22e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL6—osteoporosis	1.11e-05	9.17e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MYC—osteoporosis	1.08e-05	8.93e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFB1—osteoporosis	1.07e-05	8.91e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ADCY5—osteoporosis	1.07e-05	8.84e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—GPX1—osteoporosis	1.06e-05	8.81e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	1.06e-05	8.78e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.01e-05	8.35e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MYC—osteoporosis	1e-05	8.31e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	9.99e-06	8.29e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—POMC—osteoporosis	9.81e-06	8.14e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—MTHFR—osteoporosis	9.8e-06	8.13e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL6—osteoporosis	9.75e-06	8.09e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL6—osteoporosis	9.6e-06	7.96e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	9.4e-06	7.8e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MYC—osteoporosis	9.04e-06	7.5e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	9.02e-06	7.49e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL6—osteoporosis	8.8e-06	7.3e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	8.73e-06	7.24e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MYC—osteoporosis	8.73e-06	7.24e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFB1—osteoporosis	8.71e-06	7.23e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MYC—osteoporosis	8.68e-06	7.21e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	8.66e-06	7.19e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL6—osteoporosis	8.61e-06	7.15e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MYC—osteoporosis	8.31e-06	6.9e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	8.29e-06	6.88e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ADCY5—osteoporosis	8.22e-06	6.82e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—GPX1—osteoporosis	8.19e-06	6.8e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL6—osteoporosis	8.09e-06	6.71e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—POMC—osteoporosis	7.83e-06	6.5e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MYC—osteoporosis	7.66e-06	6.36e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFB1—osteoporosis	7.65e-06	6.34e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—MTHFR—osteoporosis	7.56e-06	6.27e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MYC—osteoporosis	7.54e-06	6.26e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6—osteoporosis	7.53e-06	6.25e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	7.52e-06	6.24e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MYC—osteoporosis	7.38e-06	6.13e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	7.37e-06	6.11e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MYC—osteoporosis	6.86e-06	5.69e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	6.84e-06	5.68e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6—osteoporosis	6.8e-06	5.64e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6—osteoporosis	6.56e-06	5.44e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6—osteoporosis	6.53e-06	5.42e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6—osteoporosis	6.25e-06	5.19e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—POMC—osteoporosis	6.05e-06	5.02e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6—osteoporosis	5.76e-06	4.78e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6—osteoporosis	5.67e-06	4.7e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6—osteoporosis	5.55e-06	4.61e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6—osteoporosis	5.16e-06	4.28e-05	CbGpPWpGaD
